A new analysis by the Epidemiology of Diabetes Interventions and Complications study group (funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health) makes a strong case for taking a more personalized approach to screening people with Type 1 Diabetes (T1D) for kidney disease. New findings suggest that urinary albumin excretion rate (AER) could be personalized to individuals with T1D to decrease costs and increase the rate of early detection.
People with T1D have about a 50% risk of developing chronic kidney disease (CKD) over their lifetime; if individuals who are at a lower risk could be tested for AER less frequently than the current once-a-year standard, the cost burden would go down. Alternatively, individuals at higher risk of developing CKD could be tested more frequently, thereby likely detecting CKD earlier and having a greater chance of slowing the progression to kidney failure and the need for dialysis and/or kidney transplant.
To learn more, read the full article on the National Institutes of Health’s website: https://www.nih.gov/news-events/news-releases/nih-funded-study-finds-personalized-kidney-screening-people-type-1-diabetes-could-reduce-costs-detect-disease-earlier
